Pacira Biosciences Inc
F:82P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
W
|
Western Alliance Bancorp
XBER:WEA
|
US |
|
Absa Group Ltd
F:AU6
|
ZA |
|
A
|
Aeroports de Paris SA
XMUN:W7L
|
FR |
|
GAIL (India) Ltd
LSE:GAID
|
IN |
|
V
|
ViacomCBS Inc
F:0VV
|
US |
|
B
|
Bhiraj Office Leasehold Real Estate Investment Trust
SET:BOFFICE
|
TH |
|
Airtel Africa PLC
OTC:AARTY
|
UK |
|
Barratt Developments P L C
LSE:BDEV
|
UK |
Wall St Price Targets
82P Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 82P is 23.55 EUR with a low forecast of 18.58 EUR and a high forecast of 31.92 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 82P's stock price target?
Price Target
23.55
EUR
According to Wall Street analysts, the average 1-year price target for 82P is 23.55 EUR with a low forecast of 18.58 EUR and a high forecast of 31.92 EUR.
What is the Revenue forecast for Pacira Biosciences Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for Pacira Biosciences Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 41%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Pacira Biosciences Inc?
Projected CAGR
110%
The compound annual growth rate for Operating Income over the next 3 years is 110%.
What is the Pre-Tax Income forecast for Pacira Biosciences Inc?
Projected CAGR
163%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 163%.
What is the Net Income forecast for Pacira Biosciences Inc?
Projected CAGR
224%
The compound annual growth rate for Net Income over the next 3 years is 224%.
